
Celerion is one of the world's leading bioanalytical contract research organizations and has been supporting pharmaceutical and biotech drug development programs around the world for more than 40 years.
Due to the steady growth of our company and to strengthen our bioanalytical laboratory in Fehraltorf / Zurich, we are looking for a
(Liquid Handling) Automation Specialist (80 – 100 %)
Your Profile
Experience with general-purpose programming languages such as Python, VB or SQL is beneficial but not required; proven Hamilton VENUS method-programming experience is essential.
We Offer You
Does this sound like the right opportunity for you? We look forward to receiving your complete application, including your CV, references, diplomas, and other relevant documents.
Additional information can be found on our website:
https://www.celerion.com/careers

Celerion, a leader in early clinical research, delivers Applied Translational Medicine. Celerion applies our expertise and experience to translating information gained in research discoveries, to knowledge of drug action and effect in humans to support early drug development decisions and the clinical pharmacology labeling of new medicines.
With over 50 years of experience and 600 global clinic beds (including 24 in-hospital), Celerion conducts and analyzes First-in-Human, clinical proof-of-concept, cardiovascular safety (TQT, robust QT), ADME and NDA-enabling clinical pharmacology studies. Celerion provides expertise on modeling and simulation, study design, medical writing (protocols and reports), clinical data sciences, biostatistics, and PK/PD analysis as well as small and large molecule bioanalytical assays through clinical drug development. Regulatory, drug development and program management complement Celerion’s service offerings.
Our operations are strategically located in:
Lincoln, Nebraska (Corporate Headquarters)
Philadelphia, Pennsylvania
Phoenix, Arizona
Belfast, Northern Ireland,UK
Zurich, Switzerland
Vienna, Austria
Richmond, Virginia
Montreal, Quebec, Canada
For more information, visit: www.celerion.com